Ticker Details
Immunocore Holdings
IPO Date:	February 5, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.81B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.02 | 2.52%
Avg Daily Range (30 D):	$0.58 | 1.84%
Avg Daily Range (90 D):	$0.55 | 1.80%

Institutional Daily Volume
Avg Daily Volume:	.28M
Avg Daily Volume (30 D):	.57M
Avg Daily Volume (90 D):	.44M

Trade Size
Avg Trade Size (Sh.):	76
Avg Trade Size (Sh.) (30 D):	94
Avg Trade Size (Sh.) (90 D):	86

Institutional Trades
Total Institutional Trades:	2,101
Avg Institutional Trade:	$1.71M
Avg Institutional Trade (30 D):	$1.43M
Avg Institutional Trade (90 D):	$1.36M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.45M
Avg Closing Trade (30 D):	$1.09M
Avg Closing Trade (90 D):	$1.03M
Avg Closing Volume:	34.68K

News

May 31, 2026 @ 12:00 PM Immunocore presents updated Phase 1 data of brenet... Source: Immunocore Holdings Plc

May 6, 2026 @ 11:00 AM Immunocore reports first quarter financial results... Source: Immunocore Holdings Plc

Apr 19, 2026 @ 10:00 PM KIMMTRAK doubles the likelihood of being alive at ... Source: Immunocore Holdings Plc

Mar 3, 2026 @ 12:00 PM Immunocore to present at upcoming investor confere... Source: Na

Feb 18, 2026 @ 12:00 PM Immunocore to report fourth quarter and full year ... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.54	$.26	$-.6
Diluted EPS	$-.55	$.25	$-.6
Revenue	$412.81M	$106.68M	$104.48M
Gross Profit	$408.12M	$106.24M	$101.78M
Net Income / Loss	$-27.57M	$12.97M	$-30.06M
Operating Income / Loss	$-34.46M	$7.28M	$-19.69M
Cost of Revenue	$4.69M	$.43M	$2.7M
Net Cash Flow	$-24.17M	$-15.03M	$-30.7M
PE Ratio